http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003180320-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
filingDate 1999-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83faff906bb024674c36f5c20f7eef3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36890711e17182a9f176f185edd6aa50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa45d9a0359a180d722e28a46b6b982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82fc760e6339075e7feabac7cd0809c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fee7e9ac034c6ae9095f015e21de8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_875970dbead52f4d5dd88ddc92f4b414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a10fd660038fdd64fa18546d801cd5c
publicationDate 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003180320-A1
titleOfInvention Attenuated salmonella strain used as a vehicle for oral immunization
abstract An attenuated strain of Salmonella typhimurium has been used as a vehicle for oral genetic immunization. Eukaryotic expression vectors containing the genes for b-galactosidase, or truncated forms of ActA and listeriolysin—two virulence factors of Listeria monocytogenes —that were controlled by an eukaryotic promoter have been used to transform a S. typhimurium aroA strain. Multiple or even single immunizations with these transformants induced a strong cytotoxic and helper T cell response as well as an excellent antibody response. Multiple immunizations with listeriolysin transformants protected the mice completely against a lethal challenge of L. monocytogenes. Partial protection was already observed with a single dose. ActA appeared not to be a protective antigen. n The strength and the kinetics of the response suggested that the heterologous antigens were expressed within the eukaryotic host cells following transfer of plasmid DNA from the bacterial carrier strain. Transfer of plasmid DNA could be unequivocally shown in vitro using primary peritoneal macrophages. The demonstration of RNA splice products and expression of β-galactosidase in the presence of tetracycline—an inhibitor of bacterial protein synthesis—indicated that the gene was expressed by host cells rather than bacteria. Oral genetic immunization with Salmonella carriers provides a highly versatile system for antigen delivery, represents a potent system to identify candidate protective antigens for vaccination, and will permit efficacious generation of antibodies against virtually any DNA segment encoding an open reading frame.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003153527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168326-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7393525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466116-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973908-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004241841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7959934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7666674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406702-B1
priorityDate 1997-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6099848-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5332658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824538-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127944238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375

Total number of triples: 58.